组织因子依赖的胆固醇性CD4+ T细胞血栓性是由活性蛋白C信号调节的
Gemma Leon1, Paula A Klavina1, Aisling M Rehill1
1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Nature communications
|February 16, 2025
概括
炎症性肠病 (IBD) 患者患有静脉血栓塞栓症 (VTE) 的风险增加. 胆固醇 CD4+ T 细胞表达组织因子 (TF),导致VTE 风险,但激活的蛋白C (PC) 信号可能会减轻这种风险.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 胃肠病学 胃肠病学
背景情况:
- 患有炎症性肠病 (IBD) 的患者患有静脉血栓塞栓症 (VTE) 的风险更高.
- 在IBD中这种增加的VTE风险背后的确切机制仍然不完全理解.
研究的目的:
- 为了研究CD4+ T细胞在IBD相关的VTE中的作用.
- 为了确定这些T细胞表达的促凝因子.
- 探索蛋白C (PC) 信号在T细胞介导的血栓发生性中的潜在调节作用.
主要方法:
- 在大肠炎的小鼠模型和IBD患者中分析CD4+T细胞上的组织因子 (TF) 表达.
- 评估TF-依赖的血栓生成.
- 在IBD组织中评估蛋白C (PC) 和其受体 (PROCR) 基因表达.
- 研究激活PC信号对TF+CD4+T细胞前凝剂活性的影响.
主要成果:
- 胆固醇 CD4+ T 细胞表达组织因子 (TF),促进血栓生成.
- 在实验性结肠炎和IBD患者组织中都发现了表达TF的CD4+T细胞.
- 蛋白C (PC) 和PROCR基因表达的失调发生在IBD肠道组织中.
- 观察到活性PC信号降低了TF+CD4+T细胞的前凝活动.
结论:
- 表达组织因子 (TF) 的CD4+T细胞有助于炎症性肠病 (IBD) 的血栓发生.
- 活性蛋白C (PC) 信号传递在缓解T细胞介导的血栓炎症活性方面起着调节作用.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
4.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.9K
Clot Retraction and Fibrinolysis
3.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.5K
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
597
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
597
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K


